TGFβ1 and TGFβ2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid

Experimental Neurology

Volumn 142, Issue 2, 1996, Pages 313-322

  Vawter, Marquis P ^c   Dillon Carter, Ora ^c   Tourtellotte, W W ^a   Carvey, Paul ^b   Freed, William J ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; ALBUMINOID; CYTOKINE; IMMUNOGLOBULIN G; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; SCHIZOPHRENIA; AGE; BLOOD BRAIN BARRIER; BRAIN VENTRICLE; CROSS REACTION; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROTEIN CEREBROSPINAL FLUID LEVEL; SEX DIFFERENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALBUMINS; ALZHEIMER DISEASE; BLOOD-BRAIN BARRIER; CEREBRAL VENTRICLES; CEREBROSPINAL FLUID PROTEINS; CROSS REACTIONS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PARKINSON DISEASE; SCHIZOPHRENIA; SEX FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030471162     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0200     Document Type: Article

References (50)

1. 1. ADAMS, R. D., AND M. VICTOR. 1989. Principles of Neurology, 4th ed. McGraw-Hill, New York.
2. 2. BEN MENACHEM, E., L. PERSSON, P. J. SCHECHTER, K. D. HAEGELE, N. HUEBERT, AND J. HARDENBERG. 1989. Cerebrospinal fluid parameters in healthy volunteers during serial lumbar punctures. J. Neurochem. 52: 632-635.
3. 3. BLENNOW, K., P. FREDMAN, A. WALLIN, C. G. GOTTFRIES, G. LANGSTROM, AND L. SVENNERHOLM. 1993. Protein analyses in cerebrospinal fluid. I. Influence of concentration gradients for proteins on cerebrospinal fluid/serum albumin ratio. Eur. Neurol. 33: 126-128.
4. 4. BLENNOW, K., A. WALLIN, AND J. K. CHONG. 1995. Cerebrospinal fluid "neuronal thread protein" comes from serum by passage over the blood-brain barrier. Neurodegeneration 4: 187-193.
5. 5. BORDER, W. A., AND N. A. NOBLE. 1994. Transforming growth factor-beta in glomerular injury. Exp. Nephrol. 2: 3-17.
6. 6. BROWN, P. D., L. M. WAKEFIELD, A. D. LEVINSON, AND M. B. SPORN. 1990. Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 3: 35-43.
7. 7. CALABRESI, P. A., A. HANHAM, J. CARLINO, H. OLSEN, H. MALONI, H. F. MCFARLAND, AND M. K. KACKE. 1995. Report of an ongoing phase I trial of recombinant transforming growth factor-beta 2 (TGF-beta2) in chronic progressive multiple sclerosis. Neurology 45: A417-A418.
8. 8. CHAO, C. C., S. HU, W. H. N., FREY, T. A. ALA, W. W. TOURTELLOTTE, AND P. K. PETERSON. 1994. Transforming growth factor beta in Alzheimer's disease. Clin. Diagn. Lab. Immunol. 1: 109-110.
9. 9. CHAO, C. C., S. HU, F. H. KRAVITZ, M. TSANG, W. R. ANDERSON, AND P. K. PETERSON. 1994. Transforming growth factor-beta protects human neurons against beta-amyloid-induced injury. Mol. Chem. Neuropathol. 23: 59-178.
10. 10. CONSTAM, D. B., P. SCHMID, A. AGUZZI, M. SCHACHNER, AND A. FONTANA. 1994. Transient production of TGF-beta 2 by postnatal cerebellar neurons and its effect on neuroblast proliferation. Eur. J. Neurosci. 6: 766-778.
11. 11. ELOVAARA, I., A. ICEN, J. PALO, AND T. ERKINJUNTTI. 1985. CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis. J. Neurol. Sci. 70: 73-80.
12. 12. FISHMAN, R. A. 1980. Cerebrospinal Fluid in Diseases of the Nervous System. Saunders, Philadelphia.
13. 13. FLANDERS, K. C., G. LUDECKER, J. RENZIG, C. HAMM, D. S. CISSEL, AND K. UNSICKER. 1993. Effect of TGF-betas and bFGF on astroglial cell growth and gene expression in vitro. Mol. Cell Neurosci. 4: 406-417.
14. 14. FLANDERS, K. C., C. F. LIPPA, T. W. SMITH, D. A. POLLEN, AND M. B. SPORN. 1995. Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology 45: 1561-1569.
15. 15. FLANDERS, K. C., G. LUDECKE, S. ENGELS, D. S. CISSEL, A. B. ROBERTS, P. KONDAIAH, R. LAFYATIS, M. B. SPORN, AND K. UNSICKER. 1991. Localization and actions of transforming growth factor-beta s in the embryonic nervous system. Development 113: 183-191.
16. 16. GRAINGER, D. J., D. E. MOSEDALE, J. C. METCALFE, P. L. WEISSBERG, AND P. R. KEMP. 1995. Active and acid-activatable TGF-beta in human sera, platelets and plasma. Clin. Chim. Acta 235: 11-31.
17. 17. HARPEL, J. G., C. N. METZ, S. KOJIMA, AND D. B. RIFKIN. 1992. Control of transforming growth factor-beta activity: Latency vs. activation. Prog. Growth Factor Res. 4: 321-335.
18. 18. HUBER, D., A. FONTANA, AND S. BODMER. 1991. Activation of human platelet-derived latent transforming growth factor-beta 1 by human glioblastoma cells. Comparison with proteolytic and glycosidic enzymes. Biochem. J. 277: 65-173.
19. 19. ISSA, F., G. A. GERHARDT, J. J. BARTKO, R. L. SUDDATH, M. LYNCH, P. H. GAMACHE, R. FREEDMAN, R. J. WYATT, AND D. G. KIRCH. 1994. A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schizophrenia: I. Comparisons with healthy control subjects and neuroleptic-treated/unmedicated pairs analyses. Psychiatry Res. 52: 237-249.
20. 20. JOHNS, L. D., K. C. FLANDERS, G. E. RANGES, AND S. SRIRAM. 1991. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. J. Immunol. 147: 1792-1796.
21. 21. KANAI, H., H. MITSUHASHI, K. ONO, S. YANO, AND T. NARUSE. 1994. Increased excretion of urinary transforming growth factor beta in patients with focal glomerular sclerosis. Nephron 66: 391-395.
22. 22. KITAZAWA, K, AND T. TADA. 1994. Elevation of transforming growth factor-beta 1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Stroke 25: 1400-1404.
23. 23. KRIEGLSTEIN, K., M. RUFER, C. SUTER-CRAZZOLARA, AND K. UNSICKER. 1995. Neural functions of the transforming growth factors beta. Int. J. Dev. Neurosci. 13: 301-315.
24. 24. KRIEGLSTEIN, K., C. SUTER-CRAZZOLARA, W. H. FISCHER, AND K. UNSICKER. 1995. TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 14: 736-742.
25. 25. KRIEGLSTEIN, K., AND K. UNSICHER. 1994. Transforming growth factor-beta promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity. Neuroscience 63: 1189-1196.
26. 26. LEONARDI, A., C. GANDOLFO, C. CAPONNETTO, L. ARATA, AND R. VECCHIA. 1985. The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid. J. Neurol. Sci. 67: 253-261.
27. 27. LINDHOLM, D., E. CASTREN, R. KIEFER, F. ZAFRA, AND H. THOENEN. 1992. Transforming growth factor-beta 1 in the rat brain: Increase after injury and inhibition of astrocyte proliferation. J. Cell Biol. 117: 95-400.
28. 28. LINK, J. 1994. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Acta Neurol. Scand. Suppl. 158: 1-58.
29. 29. LINK, J., M. SODERSTROM, T. OLSSON, B. HOJEBERG, A. LJUNGDAHL, AND H. LINK. 1994. Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis. Ann. Neurol. 36: 379-386.
30. 30. LIPPA, C. F., T. W. SMITH, AND K. C. FLANDERS. 1995. Transforming growth factor-beta: Neuronal and glial expression in CNS degenerative diseases. Neurodegeneration 4: 425-432.
31. 31. LOGAN, A., AND M. BERRY. 1993. Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS. Trends Pharmacol. Sci. 14: 337-342.
32. 32. LOGAN, A., M. BERRY, A. M. GONZALEZ, S. A. FRAUTSCHY, M. B. SPORN, AND A. BAIRD. 1994. Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci. 6: 355-363.
33. 33. LOTT, J. A., W., P. 1989. Estimation of reference intervals for total protein in cerebrospinal fluid. Clin. Chem. 35: 1766-1770.
34. 34. MOGI, M., M. HARADA, T. KONDO, H. NARABAYASHI, P. RIEDERER, AND T. NAGATSU. 1995. Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease. Neurosci. Lett. 193: 129-132.
35. 35. PAZZAGLIA, P. J., R. M. POST, D. RUBINOW, M. A. KLING, T. S. HUGGINS, AND T. SUNDERLAND. 1995. Cerebrospinal fluid total protein in patients with affective disorder. Psychiatry Res. 57: 259-266.
36. 36. PERESS, N. S., AND E. PERILLO. 1995. Differential expression of TGF-beta 1, 2 and 3 isotypes in Alzheimer's disease: A comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J. Neuropathol. Exp. Neurol. 54: 802-811.
37. 37. PETERSON, P. K., C. C. CHAO, S. HU, K. THIELEN, AND E. G. SHASKAN. 1992. Glioblastoma, transforming growth factor-beta, and Candida meningitis: A potential link. Am. J. Med. 92: 262-264.
38. 38. POULSEN, K. T., M. P. ARMANINI, R. D. KLEIN, M. A. HYNES, H. S. PHILLIPS, AND A. ROSENTHAL. 1994. TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13: 1245-1252.
39. 39. PREHN, J. H., B. PERUCHE, K. UNSICKER, AND J. KRIEGLSTEIN. 1993. Isoform-specific effects of transforming growth factors-beta on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J. Neurochem. 60: 1665-1672.
40. 40. RIFKIN, D. B., S. KOJIMA, M. ABE, AND J. G. HARPEL. 1993. TGF-beta: Structure, function, and formation. Thromb. Haemost. 70: 177-179.
41. 41. ROBERTS, A. B., AND M. B. SPORN. 1992. Differential expression of the TGF-beta isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol. Reprod. Dev. 32: 91-98.
42. 42. SNOWDEN, N., B. COUPES, A. HERRICK, K. ILLINGWORTH, M. I. JAYSON, AND P. E. BRENCHLEY. 1994. Plasma TGF beta in systemic sclerosis: Across-sectional study. Ann. Rheum. Dis. 53: 763-767.
43. 43. SPJOTVOLL, E. S., M. R. 1973. An extension of the T-method of multiple comparison to include the cases with unequal sample sizes. J. Am. Statist. Assoc. 68: 976-978.
44. 44. SYNDULKO, K., W. W. TOURTELLOTTE, A. J. CONRAD, G. IZQUUIERDO, MULTIPLE SCLEROSIS STUDY GROUP, ALPHA INTERFERON STUDY GROUP, AND AZATHIOPRINE STUDY GROUP. (1993). Transblood-brain-barrier albumin leakage and comparisons of intrathecal IgG synthesis calculations in multiple sclerosis patients. Neuroimmunology 46: 185-192.
45. 45. TOURTELLOTTE, W. W., B. TAVOLATO, J. A. PARKER, AND P. COMISO. 1971. Cerebrospinal fluid electroimmunodiffusion. An easy, rapid, sensitive, reliable, and valid method for the simultaneous determination of immunoglobulin-G and albumin. Arch. Neurol. 25: 345-350.
46. 46. UNSICKER, K. 1993. The trophic cocktail made by adrenal chromaffin cells. Exp. Neurol. 123: 167-173.
47. 47. UNSICKER, K., K. C. FLANDERS, D. S. CISSEL, R. LAFYATIS, AND M. B. SPORN. 1991. Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience 44: 613-625.
48. 48. VAN DER WAL, E. A., F. GOMEZ-PINILLA, AND C. W. COTMAN. 1993. Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. Neuroreport 4: 69-72.
49. 49. VOLLMER, T. L. 1996. Multiple sclerosis: New approaches to immunotherapy. The Neuroscientist 2: 127-136.
50. 50. YU, S. J., E. S. LO, E. J. COCHRAN, D. H. LIN, C. J. FASELIS, H. L. KLAWANS, AND P. M. CARVEY. 1994. Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture. Exp. Neurol. 126: 15-24.